SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-23-227699
Filing Date
2023-09-01
Accepted
2023-09-01 16:39:16
Documents
74
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d855529d10q.htm   iXBRL 10-Q 2055635
2 EX-31.1 d855529dex311.htm EX-31.1 9748
3 EX-31.2 d855529dex312.htm EX-31.2 9749
4 EX-32.1 d855529dex321.htm EX-32.1 5032
10 GRAPHIC g855529g25s02.jpg GRAPHIC 77841
  Complete submission text file 0001193125-23-227699.txt   8420043

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tsbx-20230630.xsd EX-101.SCH 61119
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tsbx-20230630_cal.xml EX-101.CAL 60884
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tsbx-20230630_def.xml EX-101.DEF 313530
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tsbx-20230630_lab.xml EX-101.LAB 477666
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tsbx-20230630_pre.xml EX-101.PRE 388096
68 EXTRACTED XBRL INSTANCE DOCUMENT d855529d10q_htm.xml XML 1251859
Mailing Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010
Business Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010 347-897-5988
Turnstone Biologics Corp. (Filer) CIK: 0001764974 (see all company filings)

IRS No.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41747 | Film No.: 231233075
SIC: 2836 Biological Products, (No Diagnostic Substances)